The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: A randomized controlled study

Dermatology

Volumn 214, Issue 1, 2006, Pages 61-67

  Grimalt, Ramon ^a   Mengeaud, Valérie ^b   Cambazard, Frédéric ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^c HÔPITAL NORD   (France)

Author keywords

Atopic dermatitis; Avena; Corticosteroids; Emollients

Indexed keywords

CORTICOSTEROID; DESONIDE; EMOLLIENT AGENT; EXOMEGA; LOCATOP; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG POTENCY; DRUG USE; DRUG WITHDRAWAL; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PARENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN INFLAMMATION; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; AVENA SATIVA; DERMATITIS, ATOPIC; DRUG THERAPY, COMBINATION; EMOLLIENTS; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; PLANT PREPARATIONS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33845932051     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096915     Document Type: Article

References (33)

1. Haagerup A, Bjerke T, Schiotz PO, Dahl R, Binderup HG, Tan Q, Kruse TA: Atopic dermatitis - a total genome-scan for susceptibility genes. Acta Derm Venereol 2004;84:346-352.
2. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee: Worldwide variation in prevalence of symptoms of asthma, allergic rhino-conjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-1232.
3. Laughter D, Istvan JA, Tofte SJ, Hanifin JM: The prevalence of atopic dermatitis in Oregon school children. J Am Acad Dermatol 2000;43:649-655.
4. Werner Y, Lindberg M: Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985;65:102-105.
5. Loden M: The skin barrier and use of moisturizers in atopic dermatitis. Clin Dermatol 2003;21:145-157.
6. Sator PG, Schmidt JB, Honigsmann H: Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 2003;48:352-358.
7. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991;96:523-526.
8. Imokawa G: Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol 2001;45:S29-S32.
9. Berard F, Marty JP, Nicolas JF: Allergen penetration through the skin. Eur J Dermatol 2003;13:324-330.
10. Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW, Williams ML, Elias PM: Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002;47:198-208.
11. Loden M: Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 2003;4:771-788.
12. Loden M, Andersson AC, Lindberg M: Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999;140:264-267.
13. Pigatto PD, Bigardi AS, Cannistraci C, Picardo M: 10% urea cream (Laceram) for atopic dermatitis: a clinical and laboratory evaluation. J Dermatolog Treat 1996;7:171-175.
14. Aries MF, Vaissiere C, Pinelli E, Pipy B, Charveron M: Avena Rhealba inhibits A23187-stimulated arachidonic acid mobilization, eicosanoid release, and cPLA2 expression in human keratinocytes: potential in cutaneous inflammatory disorders. Biol Pharm Bull 2005;28:601-606.
15. Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB: Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003;49:1088-1095.
16. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, Schachner LA, Sidbury R, Whitmore SE, Sieck CK, Van Voorhees AS: Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association 'Administrative Regulations for Evidence-Based Clinical Practice Guidelines'. J Am Acad Dermatol 2004;50:391-404.
17. Darsow U, Lubbe J, Taieb A, Seidenari S, Wollenberg A, Calza AM, Giusti F, Ring J; European Task Force on Atopic Dermatitis: Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005;19:286-295.
18. Williams HC: Clinical practice: atopic dermatitis. N Engl J Med 2005;352:2314-2324.
19. Lucky AW, Leach AD, Laskarzewski P, Wenck H: Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997;14:321-324.
20. Muzaffar F, Hussain I, Rani Z, Aziz A, Sultan B: Emollients as an adjunct therapy to topical corticosteroids in children with mild to moderate atopic dermatitis. J Pakistan Assoc Dermatol 2002;12:64-68.
21. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A: Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195:10-19.
22. Lewis-Jones MS, Finlay AY, Dykes PJ: The Infants' Dermatitis Quality of Life Index. Br J Dermatol 2001;144:104-110.
23. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG: The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998;138:107-113.
24. Green C, Colquitt JL, Kirby J, Davidson P: Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol 2005;152:130-141.
25. Hoare C, Li Wan Po A, Williams H: Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4:1-191.
26. Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG: Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003;149:582-589.
27. Hanifin JM, Hebert AA, Mays SR, Paller AS, Sherertz EF, Wagner AM, Tuley MR, Baker MD: Effects of a low-potency corticosteroid lotion plus moisturizing regimen in the treatment of atopic dermatitis. Curr Ther Res 1998;59:227-233.
28. Charman C, Chambers C, Williams H: Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol 2003;120:932-941.
29. Foelster-Holst R, Nagel F, Zoellner P, Spaeth D: Efficacy of crisis intervention treatment with topical corticosteroids prednicarbat with and without partial wet-wrap dressing in atopic dermatitis. Dermatology 2006;212:66-69.
30. Finlay AY: Quality of life in atopic dermatitis. J Am Acad Dermatol 2001;45:S64-S66.
31. Fivenson D, Arnold RJ, Kaniecki DJ, Cohen JL, Frech F, Finlay AY: The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm 2002;8:333-342.
32. Chamlin SL, Frieden IJ, Williams ML, Chren MM: Effects of atopic dermatitis on young American children and their families. Pediatrics 2004;114:607-611.
33. Ben-Gashir MA, Seed PT, Hay RJ: Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004;150:284-290.